Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...
Abbott recently announced the the U.S. Food and Drug Administration (FDA) cleared the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™, which has first-of-its-kind grid configuration, designed to ...
Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...
Abbott Laboratories said it is set to roll out its Volt PFA System in the U.S., following federal approval, and continue expanding the cardiology tool throughout Europe. The U.S. Food and Drug ...
San Clemente-based cardiac device company AtaCor Medical announced a collaboration with Abbott Laboratories to develop a next ...
The FDA has cleared Abbott’s Confirm Rx Insertable Cardiac Monitor (ICM), an implantable device that continuously tracks patients’ heart rhythms and sends the data to a smartphone app via Bluetooth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results